Business Description

Description
Abliva AB is a Swedish company that is active in pharmaceutical development. It develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare, and often very severe diseases occur when the cell's energy provider, the mitochondria, does not function properly. The portfolio includes projects at different stages and ranges from the early discovery phase to the clinical phase.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.88
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 0.02
9-Day RSI 1
14-Day RSI 5.26

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.61
Quick Ratio 6.61
Cash Ratio 4.61

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -77
Shareholder Yield % -0.49
Name Current Vs Industry Vs History
FCF Margin % -48366.67
ROE % -61.07
ROA % -55.24
ROIC % -102.59
ROC (Joel Greenblatt) % -9017.88
ROCE % -60.75

Financials (Next Earnings Date:2024-05-23)

NEVPF's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:NEVPF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Abliva AB Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.003
EPS (TTM) ($) -0.008
Beta 8895.81
Volatility % 115.8
14-Day RSI 5.26
14-Day ATR ($) 0.000072
20-Day SMA ($) 0.01
12-1 Month Momentum % 0
52-Week Range ($) 0.01 - 0.02
Shares Outstanding (Mil) 1,056.3

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Abliva AB Filings

Filing Date Document Date Form
No Filing Data

Abliva AB Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Abliva AB Frequently Asked Questions

What is Abliva AB(NEVPF)'s stock price today?
The current price of NEVPF is $0.01. The 52 week high of NEVPF is $0.02 and 52 week low is $0.01.
When is next earnings date of Abliva AB(NEVPF)?
The next earnings date of Abliva AB(NEVPF) is 2024-05-23.
Does Abliva AB(NEVPF) pay dividends? If so, how much?
Abliva AB(NEVPF) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1